Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework

The definition of Alzheimer’s disease (AD) now considers the presence of the markers of amyloid (A), tau deposition (T), and neurodegeneration (N) essential for diagnosis. AD patients have been reported to have increased blood–brain barrier (BBB) dysfunction, but that has not been tested within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Toniolo, Sofia, Di Lorenzo, Francesco, Bernardini, Sergio, Mercuri, Nicola Biagio, Sancesario, Giulia Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418506/
https://www.ncbi.nlm.nih.gov/pubmed/37569528
http://dx.doi.org/10.3390/ijms241512151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418506/
https://www.ncbi.nlm.nih.gov/pubmed/37569528
http://dx.doi.org/10.3390/ijms241512151

Ejemplares similares